GLAXF - GlaxoSmithKline plc

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
Currency in GBP. All numbers in thousands
Revenue31/12/201831/12/201731/12/201631/12/2015
Total revenue30,821,00030,186,00027,889,00023,923,000
Cost of revenue9,714,0009,317,0008,907,0008,853,000
Gross profit21,107,00020,869,00018,982,00015,070,000
Operating expenses
Research development3,798,0003,925,0003,550,0003,560,000
Selling general and administrative9,366,0009,256,0008,852,0009,232,000
Non-recurring----
Others309,000799,0001,292,000-269,000
Total operating expenses23,187,00023,297,00022,601,00021,376,000
Operating income or loss7,634,0006,889,0005,288,0002,547,000
Income from continuing operations
Total other income/expenses net-2,834,000-3,364,000-3,349,0007,979,000
Earnings before interest and taxes7,634,0006,889,0005,288,0002,547,000
Interest expense-754,000-720,000-701,000-719,000
Income before tax4,800,0003,525,0001,939,00010,526,000
Income tax expense754,0001,356,000877,0002,154,000
Minority interest-688,0003,557,0003,839,0003,764,000
Net income from continuing ops4,046,0002,169,0001,062,0008,372,000
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income3,623,0001,532,000912,0008,422,000
Preferred stock and other adjustments----
Net income applicable to common shares3,623,0001,532,000912,0008,422,000
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes